Malaysia secures Pfizer Covid-19 vaccine in a first for Southeast Asia

Malaysia has agreed to buy 12.8 million doses of Pfizer's COVID-19 vaccine, becoming the first country in Southeast Asia to announce a deal with the U.S.

drugmaker after some expressed reservations over the need for ultra-cold storage. While final trial data showed that Pfizer's vaccine is 95% effective, many Asian countries are not betting on it partly due to tropical heat, remote island communities and a lack of ultra-cold freezers. Pfizer's vaccine, jointly developed with German partner BioNTech, must be stored and.

This article is no longer available in our repository.

There could be multiple reasons for this.